Founded in 1979 as an independent contract research organisation (CRO), Nuvisan initially provided bioanalytical laboratory services and PK/PD studies. Over time, it expanded into other areas such as early discovery, safety testing, clinical trial management and regulatory support. The company has grown significantly, with a focus on forming partnerships to address the changing needs of its clients. In early 2024, ALS took full ownership of Nuvisan, extending its high-quality and personalised solutions to post-commercialisation and expanding its reach to provide services in more locations worldwide.
Contact Us
Search
